24 Apr

GlaxoSmithKline’s 1Q17 Estimates: Revenues Expected to Grow

WRITTEN BY Mike Benson FEATURED IN Pre-Release Earnings Reports

GlaxoSmithKline’s revenue estimates

Analysts expect ~16.5% growth in GlaxoSmithKline’s (GSK) 1Q17 revenues to ~7.3 billion pounds following strong product launches, acquired products from Novartis (NVS), and improvement in the supply chain.

GlaxoSmithKline’s 1Q17 Estimates: Revenues Expected to Grow

The above chart shows revenues for GlaxoSmithKline over the last eight quarters and estimates for 1Q17. We’ll explore the various factors affecting these expectations for future revenues.

Segment-wise expectations 1Q17

GSK’s business is divided into three business segments:

  • Pharmaceuticals segment
  • Vaccines segment
  • Consumer Healthcare segment

Since the divestment of its oncology products to Novartis in 2015, GSK’s Pharmaceuticals revenues have declined. The major factors impacting the Pharmaceuticals revenues are the decreased sales of blockbuster drugs such as Seretide and Advair. 

For 1Q17, the company’s HIV Products, including Triumeq and Tivicay, are expected to drive the growth of the Pharmaceuticals segment, which should be more than offset by lower sales of a few products such as Seretide and Advair.

The revenues from the Vaccines segment are expected to increase in 1Q17, mainly driven by the meningitis vaccines portfolio that was acquired from Novartis in March 2015.

GSK’s Consumer Healthcare revenues are expected to increase in 1Q17, mainly due to increased sales of skin health products, oral health products such as Flonase, and new products under the Sensodyne brand.

For broad-based exposure to this industry, investors can consider the First Trust Value Line 100 ETF (FVL), which holds 0.9% of its total assets in GlaxoSmithKline (GSK). FVL also holds 1.1% of its assets each in Valeant Pharmaceuticals (VRX), Teva Pharmaceuticals (TEVA), and AstraZeneca (AZN).

Latest articles

After being listed on the NASDAQ (QQQ) on March 29, Lyft (LYFT) stock has traded on a negative note so far.

23 Apr

Coca-Cola Stock Rises on Impressive Q1 Results

WRITTEN BY Sharon Bailey

Coca-Cola (KO) impressed investors with better-than-expected revenue and earnings for the first quarter.

23 Apr

Why Microsoft Bought Express Logic

WRITTEN BY Rachel Gunter

Microsoft (MSFT) announced this month that it had acquired a San Diego startup called Express Logic for an undisclosed amount.

Spirit Airlines is scheduled to report its first-quarter results on April 25. The airline has an impressive record of beating earnings estimates.

On April 23 before the market opened, legacy motorcycle maker Harley-Davidson (HOG) reported its first-quarter earnings results.

Williams Companies (WMB) is scheduled to release its first-quarter earnings on May 1 after the market closes.